Safety of high-dose iron sucrose infusion in hospitalized patients with chronic kidney disease

The safety of high-dose iron sucrose infusion in hospitalized patients with chronic kidney disease was studied. A retrospective analysis was conducted at a 478-bed community hospital. A medical informatics search was performed to identify all hospitalized patients who were prescribed i.v. iron sucrose to deliver elemental iron 300 mg every other day for three doses between January and December 2002. Patients were eligible for inclusion in the analysis if they had chronic kidney disease, had an estimated creatinine clearance of